Ranbaxy Laboratories, which has been facing regulatory hurdles in the US, has been allowed to sell generic Valsartan tablets.

Sun Pharma and Ranbaxy Labs, the rival it is in the process of acquiring, have set up an integration committee headed by Ranjan Chakravarti

Dr Reddy's Laboratories capitalised on the regulatory troubles of Indian rivals to post its highest quarterly income and operating profit d...

Shares of Ranbaxy Laboratories today gained nearly 6 per cent after the company's fourth quarter net loss narrowed to Rs 158.94 crore.

Ranbaxy Laboratories reported a 90 per cent drop in first quarter net profit compared to the same year-ago period.

Ranbaxy’s September quarter performance, which was sans the exclusivity sales of generic Lipitor, was boosted by two authorised generic lau...

Ranbaxy has launched authorized pioglitazone hydrochloride tablets, generic version of Takeda's diabetes drug sold under the brand Actos in...

Ranbaxy laboratories has received an approval for an anti acne drug Absorica developed by US firm Cipher, the company said in a release to ...

Ranbaxy net profit jumped four fold to Rs 1,246 cr for the quarter ended Mar, buoyed by gains from two exclusive drug launches in US.

Ranbaxy Laboratories Ltd on Monday said it has entered into an agreement with the Japanese drug maker Takeda Pharmaceuticals for ending the...

The global economic slowdown seems to have affected Indian generic players in the US, which is a key market for them.

Senior Ranbaxy Labs execs - Peter Burema, president (global pharma business) and Nick Haggar, head of European operations - have quit the c...

While Ranbaxy is slated to become a subsidiary of Japan’s third largest pharma company, Daiichi Sankyo, Ranbaxy’s investors may have to wai...

Pharmaceutical major Ranbaxy Laboratories on Monday said it has commercialised its first authorised generic product, Isoptin SR - an anti h...

Ranbaxy Laboratories on Monday said it has acquired the US marketing rights for 13 dermatology products from Bristol-Myers Squibb Company (...

The Ranbaxy share price dropped 5% on Thursday in the backdrop of US federal officials conducting a search on the premises of the company’s...

The net profit of Ranbaxy Laboratories has increased by 97% to Rs 520.4 crore for the year ended December 31, 2006, from Rs 264.2 in 2005.